Company: ZLAB
Filing Date: 2025-04-18
Form Type: PRE 14A
Source: 0001628280-25-018384
Chunk: 67

Company: Zai Lab Ltd
Filing Date: 2025-04-18
Form: PRE 14A
Chunk 67
---
 $                   | 1,076,400 |
|                    |     | Benefits Continuation |     |              |     | $ |      2,437 |     |                    |        |     |   |            | N/A |                     |           |     | $ |     29,245 |     |                     |           |
|                    |     | Value of Equity       
 Acceleration          |     |              |     |   |            | N/A |                    |        |     |   |            | N/A |                     |           |     | $ |  7,037,975 |     |                     |           |

* In the event of a termination due to disability, all of the named executive officers would receive the same benefits as reflected in the “Termination Due to Death” column, other than Mr. Edmondson who would receive the same benefits as reflected in the “Termination without Cause or for Good Reason” column (cash severance of $856,772, benefits continuation with a value of $39,105, and accelerated equity vesting with an estimated value of $4,243,072).

Our named executive officers are entitled to receive certain benefits upon a qualifying termination of employment, including following a change in control of the Company, or in the event of a termination of employment due to the executive’s death or disability, as described below.

Under the terms of their respective employment agreements, in the event of a termination of employment, each of our named executive officers will be entitled to receive any accrued but unpaid base salary, reimbursement for unpaid business expenses incurred prior to termination, and any additional compensation as may be expressly required under applicable law, including accrued but unused vacation time. In addition, our named executive officers, other than Dr. Chen and Mr. Smiley, will be entitled to receive additional compensation as described below upon termination of employment by us without “cause” or by the executive for “good reason” (each, a “qualifying termination”), subject to the executive’s timely execution of a separation agreement and a general release of claims in a form reasonably satisfactory to the Company, and our named executive officers, other than Dr. Chen, will also be entitled to receive additional compensation in the event of a qualifying termination within 12 months following a

<div align='center'>-51-</div>

change in control (a “change in control termination”) or as a result of death or disability, the first subject to the executive’s timely execution of a separation agreement and a general release of claims in